Résultats de recherche
Il y a 22 heures · Atrial fibrillation (AF, AFib or A-fib) is an abnormal heart rhythm (arrhythmia) characterized by rapid and irregular beating of the atrial chambers of the heart. It often begins as short periods of abnormal beating, which become longer or continuous over time.
Il y a 5 jours · L’unité de cardiologie interventionnelle exerce aussi une activité de recherche médicale qui est fondamentale pour améliorer la compréhension et le traitement des maladies cardiovasculaires. De ce fait nous participons à de nombreuses études multicentriques, nationales et internationales.
Il y a 5 jours · Affections des valves. Le cœur, pompe vitale de notre organisme, est composé de 4 cavités, les 2 oreillettes et les 2 ventricules qui sont séparées par un total de 4 valves: Du côté gauche, la valve mitrale et la valve aortique. Du côté droit, la valve tricuspide et la valve pulmonaire.
Il y a 22 heures · Wearables are increasingly used by patients with atrial fibrillation (AF) for symptom monitoring and health management, but their impact on patient health care use and psychological well‐being is not well understood. Patients with atrial fibrillation (AF) who use wearables demonstrate higher rates ...
Il y a 22 heures · Background This retrospective cohort study aims to compare the effectiveness and safety of warfarin, rivaroxaban, and dabigatran in atrial fibrillation (AF) patients with different CHA2DS2-VASc scores in northern China. Methods A retrospective cohort study was performed to evaluate anticoagulation in AF patients at the second affiliated hospital of Harbin Medical University from September 2018 ...
Il y a 4 jours · Atrial fibrillation (AF) is the most common clinical arrhythmia, with an estimated 2.2 million people in the United States and 4.5 million in the European Union afflicted with the disorder.
Il y a 5 jours · Healey JS, Hart RG, Pogue J, et al. Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W).
